Right to FDA-Approved Medicines Act

Hozzl · 2025-08-13T08:05:19Z

Explore the details of House Bill 4525 Right to FDA-Approved Medicines Act currently in Congress. Get insights into its purpose, current status, sponsors, and potential impact on undefined. Stay informed on legislative developments.

8/13/2025, 8:05 AM

Summary of Bill HR 4525

H.R. 4525, introduced in the 119th Congress on July 17, 2025, aims to safeguard individuals' access to FDA-approved medicines, as well as protect healthcare providers in providing these medicines and related information.

Read the Full Bill

Formatted Text PDF Formatted XML

Current Status of Bill HR 4525

Bill HR 4525 is currently in the status of Bill Introduced since July 17, 2025. Bill HR 4525 was introduced during Congress 119 and was introduced to the House on July 17, 2025. Bill HR 4525's most recent activity was Referred to the House Committee on Energy and Commerce. as of July 17, 2025

Bipartisan Support of Bill HR 4525

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 4525

Primary Policy Focus

Alternate Title(s) of Bill HR 4525

To protect an individuals ability to access medicines approved by the Food and Drug Administration to protect a health care providers ability to provide such medicines, and information related to such medicines.